Wendy Stock to Patient Safety
This is a "connection" page, showing publications Wendy Stock has written about Patient Safety.
Connection Strength
0.112
-
Guadecitabine (SGI-110) in treatment-naive patients with acute myeloid leukaemia: phase 2 results from a multicentre, randomised, phase 1/2 trial. Lancet Oncol. 2017 10; 18(10):1317-1326.
Score: 0.112